Completed PHASE3 INTERVENTIONAL 2-arm NCT00220766

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

IGIV-C 10% Rapid Infusion Trial in Primary Immune Deficient Patients

Sponsor: Grifols Therapeutics LLC

Conditions Agammaglobulinemia Common Variable Immunodeficiency Immunologic Deficiency Syndrome Severe Combined Immunodeficiency Wiskott-Aldrich Syndrome

Interventions Dextrose, 5% in Water Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified

Updated 8 times since 2017 Last updated: Sep 24, 2009 Started: Aug 31, 2002 Primary completion: Aug 31, 2002 Completion: Mar 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00220766, this PHASE3 trial focuses on Agammaglobulinemia and Common Variable Immunodeficiency and remains completed. Sponsored by Grifols Therapeutics LLC, it has been updated 8 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed PHASE3
Feb 2017 — Apr 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Aug 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Grifols Therapeutics LLC

Data source: Grifols Therapeutics LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Birmingham, United States , Calgary, Canada , Cleveland, United States , Columbus, United States , Denver, United States , New Orleans, United States , North Palm Beach, United States , Omaha, United States , St. Petersburg, United States , Toronto, Canada and 2 more locations